From coast to coast, state lawmakers are pushing legislation in hopes of putting a lid on rising drug prices. More than a dozen bills have been proposed that require companies to either fork over information about their costs or explain recent price hikes for some medicines.

Admirable as it is, this transparency movement is unlikely to make much, if any, difference, writes Ed Silverman of the online publication STAT.